Gibbs Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Buy
8,655
+2,368
+38% +$552K 0.28% 62
2025
Q4
$1.28M Sell
6,287
-387
-6% -$76.5K 0.31% 66
2025
Q3
$1.24M Sell
6,674
-580
-8% -$99.4K 0.28% 78
2025
Q2
$1.11M Buy
7,254
+937
+15% +$144K 0.21% 108
2025
Q1
$1.05M Buy
6,317
+2,962
+88% +$463K 0.25% 93
2024
Q4
$485K Buy
3,355
+401
+14% +$62.1K 0.13% 173
2024
Q3
$479K Buy
2,954
+714
+32% +$114K 0.16% 154
2024
Q2
$327K Buy
2,240
+800
+56% +$119K 0.13% 171
2024
Q1
$228K Buy
+1,440
New +$229K 0.13% 172

Other funds holding JNJ

Gibbs Wealth Management's JNJ Position: Q1 2026 in Review

Gibbs Wealth Management increased its Johnson & Johnson (JNJ) stake by 38% in Q1 2026, buying an estimated $552K and bringing the position to 8,655 shares worth $2.12M. The position accounts for 0.28% of the portfolio, ranked #62.

Gibbs Wealth Management first reported a position in JNJ in Q1 2024 and has held it in 9 quarters since. 4,661 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Gibbs Wealth Management held 8,655 shares of Johnson & Johnson worth $2.12M as of Q1 2026.
  • Gibbs Wealth Management bought 2,368 Johnson & Johnson shares in Q1 2026, an estimated $552K.
  • Johnson & Johnson made up 0.28% of Gibbs Wealth Management's portfolio in Q1 2026, its #62 holding.
  • Gibbs Wealth Management first reported a position in Johnson & Johnson in Q1 2024 and has held it in 9 quarters since.
  • 4,661 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.